LOGIN  |  REGISTER
Viking Therapeutics

Recent Insider Transactions - Genelux (NASDAQ: GNLX)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ GNLX Genelux
Smalling Ralph / officer: Head of Regulatory
12/18/2024
Buy
$2.29
21,100
$48K
21,100
NASDAQ GNLX Genelux
Ryder Sean / officer: General Counsel
12/18/2024
Buy
$2.29
30,000
$69K
30,000
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
12/18/2024
Buy
$2.29
39,000
$89K
39,000
NASDAQ GNLX Genelux
Cappello Joseph / officer: VP, Pharmaceutical Development
12/18/2024
Buy
$2.29
39,000
$89K
39,000
NASDAQ GNLX Genelux
Zak Lourie S. / officer: Chief Financial Officer
12/18/2024
Buy
$2.29
56,525
$129K
56,525
NASDAQ GNLX Genelux
Zindrick Thomas / director, officer: President and CEO
12/18/2024
Buy
$2.29
183,000
$419K
183,000
NASDAQ GNLX Genelux
Zindrick Thomas / director, officer: President and CEO
12/16/2024
Sell
$2.34
14,315
$33K
37,372
NASDAQ GNLX Genelux
Zak Lourie S. / officer: Chief Financial Officer
12/16/2024
Sell
$2.34
2,103
$5K
40,802
NASDAQ GNLX Genelux
Smalling Ralph / officer: Head of Regulatory
12/16/2024
Sell
$2.34
2,510
$6K
16,322
NASDAQ GNLX Genelux
Cappello Joseph / officer: VP, Pharmaceutical Development
12/16/2024
Sell
$2.34
6,300
$15K
14,653

COPYRIGHT ©2023 HEALTH STOCKS HUB